The CPMC™ is enrolling individuals in a research
study to investigate the impact of personalized medicine on health outcomes. Over
the next several years, study participants will receive personalized results for
their risks of complex diseases like cancer, heart disease and diabetes, as well
as for their ability to metabolize certain medications. Participants will be asked
to complete follow-up questionnaires to inform the medical and scientific communities
about the utility of using genome information in medical care.